Abstract:e13597 Background: Accurate identification of tumor origin is crucial for effective diagnosis and treatment, particularly in cases of metastatic tumors. Interpretable machine learning models have displayed significant potential in addressing this problem when imaging and immunohistochemistry (IHC) examinations are ineffective. In this study, we developed a panel using gene expression profiles from various tumors and constructed a robust machine learning model for precise identification of tumor origin. Methods: RNA sequencing (RNA-seq) data of 9462 tumor samples originating from 21 different organs were collected from The Cancer Genome Atlas (TCGA). We conducted feature engineering through unsupervised clustering and differential gene expression analysis, selecting a refined panel of 164 genes from a pool of over 60,000 identifiers. Subsequently, a machine learning classifier grounded in Logistic regression (LR) was trained on 9462 samples with the constructed 164-gene panel. To enhance the adaptability of our model to this task, 10-fold cross-validation was employed in the multi-class mode. Two independent test sets, the Primary tumor set (PT, n=3420, including 19 tumor types) and the Metastatic tumor set (MTP, n=100, all originating from the prostate and spread to bone, liver, etc.), were established with samples from Gene Expression Omnibus (GEO) and other published studies. Notably, all samples underwent FPKM normalization and there was no overlap between training and testing samples. Model performance was assessed using accuracy, specificity, and sensitivity metrics. Results: The 164-gene expression panel achieved a cross-validation accuracy of 96.73%. In the assessment of the PT test set, our model achieved an overall 99.62% specificity, 92.31% accuracy and 89.79% sensitivity, exhibiting performance comparable to similar models in other studies. Additionally, our model accurately traced 91% of metastatic tumors in the MTP test set to the prostate, surpassing previous lines of work by a large margin. Conclusions: Gene expression patterns reveal organ-specific characteristics that could be used to identify tumor origin. The combination of a condensed yet comprehensive gene expression panel with a robust machine learning model serves as a promising tool for tumor diagnosis. Ongoing correlative studies aim to extend predictions from tissue organs to cancer subtypes.

Study of tumor molecular diagnosis model based on artificial neural network with gene expression profile

A Method for Cancer Classification Using Ensemble Neural Networks with Gene Expression Profile

Establishment of Multiple Diagnosis Models for Colorectal Cancer with Artificial Neural Networks

Development and validation of an artificial neural network model for non-invasive gastric cancer screening and diagnosis

Classification Network of Gastric Cancer Construction Based on Genetic Algorithms and Bayesian Network

Identification of gene signatures used to recognize biological characteristics of gastric cancer upon gene expression data.

Integrated Analysis of miRNA and Gene Networks on Cancer Expression Data

Combined application of tissue microarray technique and artificial neural networks in colon tumor diagnosis

Construction and analysis of a conjunctive diagnostic model of HNSCC with random forest and artificial neural network

Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets

Microarray-based Cancer Prediction Using Single Genes

An Intelligent Search Algorithm for Feature Gene Selection of Chinese Gastric Cancer with Mrna Microarray Data

Identifying the Gene Signatures from Gene-Pathway Bipartite Network Guarantees the Robust Model Performance on Predicting the Cancer Prognosis.

Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis

Highly accurate two-gene signature for gastric cancer

Identification of glioma cancer-alerted gene markers based on a diagnostic outcome correlation analysis preferential approach.

Study on Leukemia Molecular Prediction Model with Gene Expression Profile

Artificial neural network–based diagnostic models for lung cancer combining conventional indicators with tumor markers

Tumor origin identification through machine learning and gene expression profiling.

Selection of Gastric Cancer Subgroups Marker Genes Based on Machine Learning Methods

Towards key genes identification for breast cancer survival risk with neural network models